Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human heat shock protein 70

EU orphan designation number: EU/3/13/1110   
Active ingredient: Recombinant human heat shock protein 70
Indication: Treatment of Niemann-Pick disease, type C
Sponsor: Orphazyme ApS
c/o COBIS A/S, Ole Maaløes Vej 3, DK-2200 København N, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/03/2013 Centralised Orphan - Designation EMA/OD/160/12 (2013)1603 of 12/03/2013